Company: HUM
Filing Date: 2025-03-03
Form Type: 424B5
Source: 0001628280-25-009237
Chunk: 2

Company: HUMANA INC
Filing Date: 2025-03-03
Form: 424B5
Chunk 2
---
                                            |     |  8 |
| Description of the Securities We May Issue                                                                                 |     |  9 |
| Description of the Debt Securities                                                                                         |     | 13 |
| Description of the Preferred Stock and the Depositary Shares Representing Fractional or Multiple Shares of Preferred Stock |     | 15 |
| Description of the Common Stock                                                                                            |     | 17 |
| Description of the Securities Warrants                                                                                     |     | 20 |
| Plan of Distribution                                                                                                       |     | 21 |
| Legal Matters                                                                                                              |     | 23 |
| Experts                                                                                                                    |     | 23 |

### ABOUT THIS PROSPECTUS SUPPLEMENT
These offering materials consist of two documents and the information incorporated by reference in these two documents: this prospectus supplement, which describes the terms of the notes that we are currently offering, and the accompanying prospectus, which provides general information about us and our debt securities, some of which may not apply to the notes that we are currently offering. If information in this prospectus supplement, or the information incorporated by reference in this prospectus supplement, is inconsistent with, updates or changes the information in the accompanying prospectus or the information incorporated by reference in the accompanying prospectus, this prospectus supplement, or the information incorporated by reference in this prospectus supplement, will apply and will supersede that information in the accompanying prospectus or the information incorporated by reference in the accompanying prospectus. In addition, the information in this prospectus supplement may add to, update or change the information incorporated by reference in this prospectus supplement and accordingly will supersede that information.

It is important for you to read and consider all information contained in this prospectus supplement and the accompanying prospectus in making your investment decision. You should also read and consider the information in the documents incorporated by reference in this prospectus supplement and the accompanying prospectus, referred to in “Incorporation of Certain Documents by Reference” in this prospectus supplement and the accompanying prospectus.

Unless otherwise specified, all references in this prospectus supplement to:

• “Humana,” the “issuer,” “we,” “us,” “our” and the “Company” are to Humana Inc., a Delaware corporation, and its consolidated subsidiaries, unless the context otherwise requires; and

• “underwriters” are to the firms listed in “Underwriting” in this prospectus supplement.

### FORWARD-LOOKING STATEMENTS
This prospectus supplement, the accompanying prospectus and any documents we incorporate by reference in this prospect